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Abstract
Background: Epidemiological studies link organophosphorus pesticide (OP) exposures to asthma, and we have shown that
the OPs chlorpyrifos, diazinon and parathion cause airway hyperreactivity in guinea pigs 24 hr after a single subcutaneous
injection. OP-induced airway hyperreactivity involves M2 muscarinic receptor dysfunction on airway nerves independent of
acetylcholinesterase (AChE) inhibition, but how OPs inhibit neuronal M2 receptors in airways is not known. In the central
nervous system, OPs interact directly with neurons to alter muscarinic receptor function or expression; therefore, in this
study we tested whether the OP parathion or its oxon metabolite, paraoxon, might decrease M2 receptor function on
peripheral neurons via similar direct mechanisms.
Methodology/Principal Findings: Intravenous administration of paraoxon, but not parathion, caused acute frequency-
dependent potentiation of vagally-induced bronchoconstriction and increased electrical field stimulation (EFS)-induced
contractions in isolated trachea independent of AChE inhibition. However, paraoxon had no effect on vagally-induced
bradycardia in intact guinea pigs or EFS-induced contractions in isolated ileum, suggesting mechanisms other than
pharmacologic antagonism of M2 receptors. Paraoxon did not alter M2 receptor expression in cultured cells at the mRNA or
protein level as determined by quantitative RT-PCR and radio-ligand binding assays, respectively. Additionally, a biotin-
labeled fluorophosphonate, which was used as a probe to identify molecular targets phosphorylated by OPs, did not
phosphorylate proteins in guinea pig cardiac membranes that were recognized by M2 receptor antibodies.
Conclusions/Significance: These data indicate that neither direct pharmacologic antagonism nor downregulated
expression of M2 receptors contributes to OP inhibition of M2 function in airway nerves, adding to the growing evidence
of non-cholinergic mechanisms of OP neurotoxicity.
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Introduction
Asthma prevalence and severity has increased over the past two
decades, with the greatest increase occurring in children and
adolescents living in urban environments [1,2]. Over this same
period, the use of organophosphorus pesticides (OPs) has increased
not only in agricultural environments [3–6] but also significantly in
residential and urban settings [7–11]. Currently, OPs are the most
widely used chemical pesticides in the United States and throughout
the world [12], and are approved for a variety of commercial
and household applications, including control of cockroach antigen
[7–10], which is thought to be a primary trigger of asthma [13,14].
Epidemiological and clinical studies have linked OP exposures to
symptoms associated with asthma including airway hyperreactivity
and wheezing [15–23]. Consistent with these findings from human
studies, it has been reported that OPs induce bronchospasm in a
variety of animals [24,25], and we have recently established that the
OPs chlorpyrifos, parathion and diazinon induce airway hyperreac-
tivity in a guinea pig model [26,27].
It is widely postulated that OPs trigger airway hyperreactivity
via inhibition of acetylcholinesterase (AChE, E.C. 3.1.1.7) [28,29],
which decreases hydrolysis of acetylcholine (ACh) [29,30] resulting
in bronchoconstriction via prolonged activation of M3 muscarinic
receptors on airway smooth muscle [31–33]. However, we
observed that OPs potentiated vagally-induced bronchoconstric-
tion in the guinea pig in the absence of AChE inhibition [26,27].
Rather, the mechanism involved decreased function of autoinhi-
bitory M2 muscarinic receptors on the parasympathetic nerves
supplying airway smooth muscle [26,27]. Activation of these M2
receptors functions as a negative feedback mechanism, decreasing
ACh release from prejunctional parasympathetic nerves to limit
vagally-induced bronchoconstriction [31,34,35]. Loss of M2
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receptor function leads to increased ACh release from parasym-
pathetic nerves resulting in potentiation of vagally mediated
bronchoconstriction, which contributes to airway hyperreactivity.
OP-induced inhibition of M2 receptor function in airway nerves
and the consequent airway hyperreactivity is consistent with
previous studies demonstrating that neuronal M2 receptors are
dysfunctional in animal models of antigen-, virus- or ozone-
induced airway hyperreactivity [36–38], and in patients with
asthma [39].
What is not yet clear is how OPs decrease M2 receptor function
in airway nerves. Studies of antigen-induced airway hyperreactiv-
ity have established a role for a specific inflammatory cell, the
eosinophil, in causing M2 receptor dysfunction in airway nerves
[40–43]. Similar studies of OP-induced airway hyperreactivity in
guinea pigs revealed that the contribution of eosinophils to M2
dysfunction in animals exposed to the OP parathion varies with
atopic status. Pre-treatment with an antibody to interleukin-5 to
deplete eosinophils effectively prevented parathion-induced airway
hyperreactivity in guinea pigs sensitized to ovalbumin protein, but
had no effect in naı¨ve animals [44], indicating that mechanism(s)
independent of eosinophils underlie OP-induced M2 receptor
dysfunction in non-atopic individuals.
Plausible alternative mechanism(s) by which OPs might cause
neuronal M2 receptor dysfunction in airway nerves of non-atopic
individuals include direct pharmacologic antagonism of M2
receptor function or direct interactions with neurons to downreg-
ulate M2 receptor expression. There are numerous reports
documenting the ability of OPs to modulate muscarinic receptor
function and/or expression in the brain independent of AChE
inhibition (reviewed in [45,46]). Whether similar interactions
occur between OPs and peripheral neurons is not known, but that
such interactions might be functionally significant in airway
hyperreactivity is suggested by studies implicating decreased M2
receptor expression in virally induced airway hyperreactivity [47–
49]. Therefore, in this study, we tested the hypothesis that the OP
parathion, which we previously demonstrated causes airway
hyperreactivity via inhibition of M2 receptor function in airway
nerves [26], directly antagonizes M2 receptor function or
downregulates M2 receptor expression in peripheral airway
nerves. Our findings do not support this hypothesis, suggesting
that OPs inhibit M2 receptor function in the airways of non-atopic
individuals via indirect mechanisms involving a yet to be identified
intermediary cell.
Results
Acute in vivo effects of parathion or paraoxon
administered intravenously
Intravenous administration of parathion (1 mg/kg) or paraoxon
(100 ng/kg and 100 mg/kg) did not change resting inflation pressure
(216. 67627.34 mmH2O before and 226.67624.30 mH2O after
parathion; 131.4615.0 mmH20 before and 135.7613.8 mmH2O
after paraoxon) or heart rate (303.3367.15 beats per min before and
303.3368.73 beats per min after parathion; 267.165.9 beats per min
before and 263.666.6 beats per min after paraoxon) in anesthetized
guinea pigs. Electrical stimulation of both vagus nerves induced
reproducible bronchconstrictions that were frequency dependent and
atropine sensitive (data not shown), demonstrating that this effect was
mediated by release of ACh onto postjunctional muscarinic receptors.
Parathion inhibited vagally-induced bronchoconstriction at all
frequencies tested; in contrast, paraoxon caused a dose- and
frequency-dependent potentiation of vagally-induced bronchocon-
striction that did not reach statistical significance (Figure 1A).
Bronchoconstriction induced by intravenous acetylcholine (ACh)
was reproducible, reversible and blocked by atropine (data not
shown). ACh-induced bronchoconstriction was not affected by
100 ng/kg paraoxon but was potentiated by 100 mg/kg paraoxon
(Figure 1B). However, this higher dose of paraoxon significantly
inhibited AChE activity in circulating blood, as did parathion
(Figure 1C).
Electrical stimulation of vagus nerves and intravenous ACh
both caused bradycardia that was reproducible and blocked by
atropine (data not shown). However, no dose of parathion or
paraoxon significantly altered vagally-induced bradycardia
(Figure 2A). Paraoxon at 100 mg/kg but not 100 ng/kg increased
ACh-induced bradycardia but this effect did not reach statistical
significance (Figure 2B).
Effects of paraoxon on activity-induced contraction in
isolated trachea and ileum
Electrical field stimulation (EFS) of isolated guinea pig
trachea and ileum caused reproducible contractions that were
blocked by atropine (data not shown). Exogenous ACh (5 mM)
also induced atropine-sensitive contractions. Paraoxon at
360 nM but not 100 nM caused a significant, time-dependent
increase in EFS-induced contractions in the trachea (Figure 3A,
left panel). Paraoxon at 1.0 mM caused a less robust but
statistically significant increase in EFS-induced contractions in
the ileum (Figure 3B, left panel). Paraoxon at 100 and 360 nM
significantly increased ACh-induced contractions in the trachea
(Figure 3A, right panel); in contrast, paraoxon had no effect on
ACh-induced contractions in the ileum at any concentration
(Figure 3B, middle panel). Vehicle (DMSO) did not alter EFS-
or ACh induced contractions in the ileum or trachea. Tissue
AChE levels were measured to determine whether paraoxon-
induced potentiation of contractions were related to AChE
inhibition. In the ileum, paraoxon at 360 nM and 1 mM
significantly inhibited AChE activity (Figure 3B, right panel).
To measure detectable AChE activity in isolated trachea
segments, tracheas from 2 experiments were pooled. Tracheas
exposed to 0.1% DMSO, 100 nM paraoxon, and 360 nM
paraoxon respectively converted on average 1.65, 0.95, and
0.6 mmol substrate/min/mg protein, suggesting paraoxon
inhibited AChE activity in the trachea.
The lack of direct correlation between OP-induced potentiation
of activity-induced smooth muscle contractions and inhibition of
AChE activity suggested that the mechanism of increased
contraction in response to OPs is not AChE inhibition. To further
test this hypothesis, the effects of physostigmine, a reversible AChE
inhibitor, were measured in isolated ileum. Physostigmine did not
increase EFS-induced contractions (Figure 3C, left panel) at
concentrations that significantly inhibited AChE activity
(Figure 3C, right panel).
Paraoxon does not modulate M2 muscarinic receptor
mRNA or protein
It is difficult to obtain parasympathetic neurons of sufficient
homogeneity for quantitative RT-PCR analyses of neuronal
mRNA [50]. Thus, to determine whether OPs might alter M2
receptor expression, M2 transcript levels were quantified by
quantitative RT-PCR in SK-N-SH cells (a human neuroblastoma
cell line) and in sympathetic neurons cultured from perinatal rat
superior cervical ganglia (treated with anti-mitotic to remove non-
neuronal cells prior to experimentation) following exposure to
paraoxon (0.1–1000 nM) or vehicle (0.1% DMSO) for 4 or 24 hr.
Paraoxon had no significant effect on expression of mRNA
encoding M2 receptors in either SK-N-SH cells (Figure 4A) or
Parathion and M2 Receptors
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sympathetic neurons (Figure 4B). In contrast, as previously
reported [51], M2 mRNA levels were significantly decreased in
SK-N-SH cells following a 4 hr exposure to TNFa (2 ng/ml).
Muscarinic receptor expression was also measured at the
protein level in primary cultures of purified sympathetic neurons
(Figure 5A) and in Cos-7 cells expressing cDNA encoding the full
length human M2 receptor sequence (Figure 5 B and C). Cultures
were exposed to paraoxon or vehicle (0.1% DMSO) for 24 hr in
the absence or presence of the muscarinic agonist carbachol
(1 mM). Carbachol alone significantly decreased [3H]-NMS
binding in both sympathetic neurons and Cos-7 cells (Figure 5A
and B, white bars) but did not affect [3H]-QNB binding in the
Cos-7 cells (Figure 5C, white bars). Paraoxon alone did not affect
[3H]-NMS in either sympathetic neurons or Cos-7 cells (Figure 5A
and B, gray bars) or [3H]-QNB binding in Cos-7 cells (Figure 5C,
gray bars). Neither did paraoxon affect carbachol-induced
decreases in [3H]-NMS binding in either cell type (Figure 5A
and B, black bars).
M2 muscarinic receptors are not phosphorylated
Previous studies have shown that a biotinylated organophos-
phorus fluorophosphonate (FP-biotin) reacts with AChE, phos-
phorylating the critical serine residue that is targeted by OPs to
inhibit the enzymatic activity of AChE [52], and that it can be
used as a probe for identifying other proteins that are
phosphorylated by OPs, including bovine serum albumin (BSA)
[53]. Therefore, to test the hypothesis that parathion or
paraoxon inhibit M2 receptor function via phosphorylation,
guinea pig heart membranes were reacted with FP-biotin. BSA
(0.5 mg/ml) was also incubated with the FP-biotin as a positive
control. Protein blots were reacted with streptavidin tagged with
an infrared fluorophore to visualize bands containing biotiny-
lated proteins (Figure 6; top panel) and re-probed with anti-M2
receptor antibody to identify bands corresponding to the M2
receptor (Figure 6; middle panel). Streptavidin reacted with BSA
and with several proteins in heart membranes, demonstrating
that FP-biotin phosphorylated proteins in the heart membrane.
Antibody specific for the M2 receptor did not bind to BSA, but
did bind to a protein in heart membranes with a molecular
weight consistent with that of the M2 receptor (Figure 6, middle
panel). However, there was no overlap between proteins in the
heart membranes that reacted with the FP-biotin and those
recognized by the M2 receptor antibody (Figure 6, bottom
panel).
Figure 1. Effects of acute intravenous administration of parathion or paraoxon on bronchoconstriction in guinea pigs.
Bronchoconstriction was measured in anesthetized guinea pigs in response to electrical stimulation of both vagus nerves or to intravenous ACh
before and after intravenous administration of parathion (1 mg/kg) or paraoxon (100 ng/kg or 100 mg/kg). Baseline bronchoconstrictions were within
normal physiological parameters (8–17 mmH2O at 5 Hz, 17–59 mmH2O at 10 Hz, and 51–127 mmH2O at 15 Hz). Parathion (hatched bars) inhibited
vagally-induced bronchoconstriction by approximately 50% at all three frequencies (A). In contrast, paraoxon at 100 ng/kg (gray bars) and 100 mg/kg
(black bars) acutely increased vagally-induced bronchoconstriction in a frequency-dependent manner (A). Paraoxon at 100 ng/kg did not potentiate
ACh-induced bronchoconstriction (B) or significantly inhibit AChE activity (C). However, at 100 mg/kg, paraoxon potentiated ACh-induced
bronchoconstriction (B) and inhibited AChE (C). Data are presented as mean 6 SE; n = 3–4 guinea pigs (* p,0.05).
doi:10.1371/journal.pone.0010562.g001
Parathion and M2 Receptors
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Discussion
We have previously established that the organophosphorus
pesticides chlorpyrifos, diazinon and parathion cause airway
hyperreactivity in guinea pigs [26,27]. This effect is mediated by
blockade of inhibitory M2 muscarinic receptors [26] that normally
function to inhibit acetylcholine release from airway parasympa-
thetic nerves [34]. A significant body of literature shows that OPs
can interact directly with muscarinic receptors in the brain and
heart, although the nature of this interaction (agonism, competitive
antagonism or allosteric inhibition) varies according to OP and cell
type (reviewed in [46,54]). Thus, our initial hypothesis was that
OPs interact directly with M2 receptors on parasympathetic
nerves in the airways to antagonize M2 receptor function or
downregulate M2 receptor expression.
To test for direct antagonism, we first determined whether
parathion or its oxon metabolite, paraoxon, caused acute
potentiation of nerve-induced airway smooth muscle contractions.
In contrast to our previous demonstration that parathion
potentiates vagally-induced bronchoconstriction in guinea pigs
24 hr after a single subcutaneous injection at 1 mg/kg [26,44],
acute i.v. administration of parathion at the same dose inhibited
bronchoconstriction by 50% (Figure 1). The mechanism(s)
underlying the paradoxical effect of acutely administered parathi-
on is unlikely to include blockade of nerve conduction given that
vagally-induced bradycardia was not similarly decreased (Figure 2).
While the lack of effect on vagally-induced bradycardia suggests
that parathion is not blocking postjunctional M2 receptors in the
heart, acute i.v. parathion may be antagonizing postjunctional M3
receptors [55–58] or inhibiting signaling cascades that mediate
airway smooth contraction [55,58–60]; however, the exact
mechanism has yet to be determined.
In contrast, acute i.v. administration of paraoxon increased
vagally-induced bronchoconstriction in a frequency and dose-
dependent manner (Figure 1). The increase was consistent but
small and not statistically significant. It is unlikely that this
potentiation was due to inhibition of AChE since paraoxon had no
(100 ng/ml) or a small (100 mg/ml) effect on AChE activity in the
blood. In addition, it has been shown that inhibition of AChE
actually decreases acetylcholine release from airway nerves due to
increased activity of the inhibitory neuronal M2 receptors [61].
While these data support the possibility that these OPs interfere
directly with neuronal M2 receptor function in airways, they do
not explain the robust effects observed 24 hr and 7 d after
subcutaneous OP administration [26,27].
To further explore the hypothesis that OPs pharmacologically
antagonize M2 receptors in autonomic nerves, we examined the
direct effects of paraoxon on smooth muscle contraction in isolated
trachea. These organ bath experiments allow the direct applica-
tion of OPs to tracheal muscle, avoiding any dilution effects with
i.v. administrations. Paraoxon increased EFS-induced tracheal
muscle contraction, but this effect was slow in onset and the same
treatment also potentiated ACh-induced muscle contraction
(Figure 3). Because of the low levels of AChE activity in the
trachea, we were unable to reliably measure AChE activity, thus
we cannot exclude the possibility that paraoxon was potentiating
tracheal smooth muscle contraction via AChE inhibition.
Therefore, we repeated these studies in isolated ileum, which also
Figure 2. Acute intravenous administration of parathion or paraoxon did not significantly potentiate bradycardia in guinea pigs.
Bradycardia was measured in anesthetized guinea pigs in response to electrical stimulation of both vagus nerves or to intravenous ACh before and after
intravenous administration of parathion (1 mg/kg) or paraoxon (100 ng/kg or 100 mg/kg). None of the OP treatments had any effect on vagally-induced
bradycardia at any of the frequencies tested (A). Baseline bradycardia at 5, 10, and 15 Hz was 37.6264.13, 103.89633.15, and 155.95630.16 beats per
minute before 100 ng/kg paraoxon administration, 47.78622.82, 132.94612.43, and 218.3369.62 beats per minute before 100 mg/kg paraoxon
administration, and 41.6764.41, 85.0067.64, and 203.3366.67 beats per minute before 1.0 mg/kg parathion administration. (B) The higher dose of
paraoxon (100 mg/kg) slightly but not significantly potentiated ACh-induced bradycardia. Data are presented as mean 6 SE; n=4–7 guinea pigs.
doi:10.1371/journal.pone.0010562.g002
Parathion and M2 Receptors
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express inhibitory M2 receptors on parasympathetic nerves that
regulate smooth muscle contraction [62]. Paraoxon at 360 nM but
not at 100 nM or 1 mM increased EFS-induced ileal smooth
muscle contraction; while this increase was statistically significant,
it was of such small magnitude that it is unlikely to be
physiologically relevant (Figure 3). No concentration of paraoxon
increased ACh-induced contraction despite significant inhibition
of AChE at the two higher doses. Similarly, concentrations of the
AChE inhibitor physostigmine that significantly inhibited AChE
had no potentiating effect on EFS-induced ileal smooth muscle
contraction (Figure 3C). Collectively, these in vivo and ex vivo data
indicate there is no relationship between AChE inhibition and
potentiation of nerve-induced smooth muscle contraction in the
lung, heart or ileum, which is consistent with our previous findings
Figure 3. Paraoxon potentiates electrical field stimulation (EFS)-induced contractions in isolated guinea pig trachea and ileum.
Contractions in response to EFS (10 Hz, 100 V, 0.2 ms, 5 s duration every 30 s) and ACh (5 mM) were measured in trachea (A) and ileum (B) before and
after addition of paraoxon or vehicle (DMSO, 0.1% final). EFS induced contraction was measured for 30 min after drug treatment, while ACh-induced
contractions were measured 35 min after drug treatment. (A) Paraoxon potentiated EFS-induced contractions in the trachea with significant effects at
360 nM; paraoxon at 100 and 360 nM significantly potentiated ACh-induced contractions. (B) In contrast, paraoxon did not significantly potentiate
either EFS-induced or ACh-induced contractions in the ileum even at concentrations that significantly inhibited AChE activity. (C) Concentrations of
physostigmine that significantly inhibited AChE activity to the same degree as paraoxon did not potentiate EFS-induced contractions in the ileum.
Data are presented as mean 6 SE; n = 4–6 guinea pigs (*p,0.05).
doi:10.1371/journal.pone.0010562.g003
Parathion and M2 Receptors
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[26,27]. Moreover, these data do not support the hypothesis that
OPs directly antagonize M2 function in autonomic nerves.
Muscarinic receptor function is dependent on receptor
expression that can be regulated at both transcriptional [51] and
post-translational levels [63,64]; however, our data do not support
any of these mechanisms for OP-induced M2 receptor dysfunction
in airways observed 24 hr or 7d post-exposure [26,27].
Specifically, paraoxon did not change transcript levels for M2
receptors in the human SK-N-SH neuronal cell line or in primary
rat sympathetic nerve cultures (Figure 4). Although carbachol
induced internalization of M2 receptors in sympathetic nerves and
Cos-7 cells expressing human M2 receptors, paraoxon did not
cause M2 receptor internalization or interfere with carbachol-
induced receptor internalization (Figure 5), which is consistent
with previous reports that chlorpyrifos oxon also did not alter
receptor internalization in several different cell lines transfected
with cDNA encoding M2 receptors [63]. In contrast to previous
reports suggesting that chlorpyrifos directly phosphorylates M2
receptors in rat heart [64], we did not observe phosphorylation of
guinea pig cardiac M2 receptors using an FP-biotin probe [52].
The lack of covalent modification of M2 receptors may be due to a
number of factors, including less access to reactive M2 residues by
the large and lipophilic FP-biotin or a change in leaving group
from trichloropyridinol (chlorpyrifos) to fluoride (FP-biotin). It is
also possible that there is no discrepancy between the previous
study and our findings since the phosphorylated band pulled down
from lysates of rat heart treated in vitro with chlorpyrifos [64] was
not re-probed with M2 specific antibodies to confirm its identity as
the M2 receptor.
Although the current paradigm is that OPs interact directly with
muscarinic receptors to either stimulate or inhibit their function
(reviewed in [46,54]), we are unable to demonstrate any direct
interaction between the active metabolite of parathion and M2
muscarinic receptors. This adds to the growing body of literature
suggesting that regulation of M2 receptors [65–68]and effects of
OPs on muscarinic receptors [57,63,69–71] vary with tissue and
cell type. None-theless, when measured 24 hr or 7 d post-
exposure, OPs cause airway hyperreactivity in vivo and this effect is
mediated by loss of M2 receptor function in parasympathetic
nerves innervating airway smooth muscle [26,27]. The time course
suggests that the effects of OPs on neuronal M2 receptors require
intermediate cells, such as inflammatory cells. We have shown in
guinea pigs that are sensitized to ovalbumin that eosinophils
mediate OP-induced airway hyperreactivity; however, eosinophils
are not necessary for OP-induced airway hyperreactivity in non-
sensitized guinea pigs [44]. There are other inflammatory cell
types resident in the lungs including macrophages, mast cells and
neutrophils, all of which have been implicated in airway
hyperreactivity triggered by other stimuli [72], including viral
infection [73] and ozone exposure [74].
There is experimental evidence that OPs can affect inflamma-
tory cells. Malathion stimulates mouse macrophages to generate
reactive oxygen species (ROS) and cathepsin D [75–77], and
potentiates macrophage phagocytosis [78]. Malathion also stim-
ulates mast cell degranulation in the intestine and skin [79] and
histamine release from mast cells [80] and basophils [81]. In vivo,
OP activation of macrophages may occur indirectly via mast cells
or prostaglandins, since depletion of the former or blockade of the
latter prevents malathion-induced macrophage activation in mice
[82]. Inhalation of sarin, an OP nerve agent, induces an
inflammatory response in the lungs of guinea pigs [83] and
rats[84], measured as increased levels of inflammatory mediators,
such as histamine and prostaglandins; increased numbers of
inflammatory cells, such as eosinophils and macrophages; or
increased mRNA expression for pro-inflammatory cytokines, such
as IL-1b, IL-6 and TNFa. Studies of neutrophil activity from OP-
exposed workers suggest that neutrophil chemotaxis may be
decreased [85], although ex vivo exposure of human whole blood
Figure 4. Neuronal M2 muscarinic receptor mRNA expression is
not altered by paraoxon. (A) M2 receptor transcript levels in human
SN-N-SH cells were not changed by exposure to paraoxon (0.1–
1000 nM) for either 4 hr (gray bars) or 24 hr (black bars), while TNFa
(2 ng/ml, 4 hour exposure, white bar) significantly suppressed M2
expression. (B) Exposure for 24 hr to a similar range of paraoxon
concentrations had no effect on M2 mRNA levels in rat sympathetic
neurons. Data are expressed as a % of control levels (cultures exposed
to 0.1% DMSO) and are presented as mean 6 SE; n = 3 independent
cultures per treatment group (*p,0.05).
doi:10.1371/journal.pone.0010562.g004
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cultures, containing neutrophils and other inflammatory cells, to
chlorpyrifos potentiated LPS-induced release of IFNc [86].
Collectively, these observations strongly suggest that OPs may
increase inflammatory cytokines in the airways via stimulation of
inflammatory cells. Since it is known that proinflammatory
cytokines such as IFNc, TNFa and IL-1b can decrease M2
expression and function in vivo [47,51,87], we hypothesize that
these other inflammatory cells may be critical to OP-induced
airway hyperreactivity in non-sensitized individuals. Future
experiments should address whether these multiple, inflammatory
pathways mediate the effects of OPs on neuronal M2 receptor
dysfunction in airways.
Materials and Methods
Animals
All protocols involving animals were approved by the Animal
Care and Use Committees at Oregon Health & Science University
and the University of California at Davis. Specific pathogen-free
female Dunkin-Hartley guinea pigs (300–350 g) were purchased
from Elm Hill Labs (Chelmsford, MA) and housed in rooms with
high-efficiency particulate-filtered air. Timed-pregnant Sprague-
Dawley rats were purchased from Charles River (Wilmington,
MA) and maintained under standard housing conditions with ad
libitum access to food and water.
OPs
Parathion (o,o-diethyl-o-p-nitrophenyl phosphorothioate, 99.5%
pure) and paraoxon (diethyl-p-nitrophenylphosphate, 98.6% pure)
were purchased from Chem Service (West Chester, PA) and used
prior to the expiration date with interim storage as recommended
by the manufacturer. These OPs were suspended in dimethyl
sulfoxide (DMSO) and diluted in buffer or tissue culture media
immediately prior to experiments such that final DMSO
concentrations never exceeded 0.1%. The biotinylated organo-
phosphorus fluorophosphonate, FP-biotin, [10-(fluoroethoxypho-
sphinyl)-N-(biotinamidopentyl)decanamide] was synthesized as
previously described [52].
In vivo measurement of bronchoconstriction and
bradycardia
Physiological experiments measuring airway function in guinea
pigs were performed as previously described [88]. Guinea pigs
were chosen for these studies because their lung pharmacology is
similar to humans [89]. In addition, organophosphorus pesticides
uniformly cause airway hyperreactivity in guinea pigs unlike mice
which respond differently dependent upon the strain [90,91].
Guinea pigs were anesthetized with urethane (1.9 g/kg ip, Sigma-
Aldrich, St. Louis, MO), tracheostomized, and mechanically
ventilated with positive pressure and constant volume (100
breaths/min; 1 ml volume/100 g body weight). Jugular veins
were cannulated for drug administration, and a carotid artery was
cannulated to monitor blood pressure and heart rate. Both vagus
nerves were cut and the distal ends placed on electrodes and
Figure 5. Paraoxon does not alter expression of M2 muscarinic
receptor protein. Rat sympathetic neurons in cell culture (A) or Cos-7
cells transfected with full length cDNA encoding human M2 receptor (B)
were treated with paraoxon (1–1000 nM) or vehicle (0.1% DMSO) for
24 hr in the absence or presence of carbachol (1 mM). Muscarinic
receptor expression was determined as specific binding of [3H]-NMS
(1 nM; surface receptors) or [3H]-QNB (1 nM; total receptors) in the
absence (total) or presence (non-specific binding) of atropine (0.1 M). In
both cell types, carbachol significantly decreased [3H]-NMS (A and B,
open bars), but not [3H]-QNB (C, open bars) binding. In both
sympathetic neurons (A) and Cos-7 cells (B), paraoxon had no effect
on [3H]-NMS or [3H]-QNB binding in the absence or presence of
carbachol. Data are represented as mean 6 SE; n = 3–5.
doi:10.1371/journal.pone.0010562.g005
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submerged in mineral oil. Pulmonary inflation pressure was
measured using a pressure transducer (Becton Dickinson, Franklin
Lakes, NJ) attached to a side arm of the tracheal cannula.
Bronchoconstriction was measured as an increase in pulmonary
inflation pressure (in mm H2O) over baseline ventilator pressure.
The vagus nerves were stimulated at one minute intervals (10 V,
10 Hz, 0.2 ms, 5 s duration) for a maximum of 10 min until
vagally-induced bronchoconstriction became consistent. After this
initial warm up, bronchoconstriction and bradycardia in response
to electrical stimulation of the vagus nerves (3 times each at 5, 10
and 15 Hz; at 10V, 0.2 ms, 5 s duration) and then to 2
administrations of exogenous ACh (3 mg/kg, i.v.) was measured.
This sequence of vagally-induced bronchoconstriction followed by
ACh-induced bronchoconstriction was repeated until two repro-
ducible sequences were recorded, and then either paraoxon
(100 ng/kg or 100 mg/kg) or parathion (1 mg/kg) was adminis-
tered intravenously. The doses of paraoxon were calculated based
on our previous findings that 10 mg/kg parathion caused airway
hyperreactivity 24 hr after exposure [44], and that paraoxon is
100–1000 times more potent than parathion in inhibiting AChE
activity [92]. Within 1 min after OP administration, another
sequence of vagally- and ACh-induced bronchoconstriction was
recorded and bronchoconstric-tion at each frequency and ACh
administration were averaged.
Organ bath experiments
Experiments with isolated tissues were carried out as previously
described [93]. Briefly, guinea pigs were killed by overdose of
sodium pentobarbital (150 mg/kg; i.p.). The trachea and ileum
were removed and cut transversely into sections consisting of 3–5
cartilaginous rings (trachea) or segments measuring 1–1.5 cm
(ileum). Tissues were mounted horizontally (trachea) or vertically
(ileum) between zigzag platinum electrodes and attached to a high
sensitivity force displacement transducer (Radnotti Glass Tech-
nology, Inc., Monrovia, CA) in organ baths containing 5 ml
Krebs-Henseleit solution and allowed to equilibrate for 30 min
under 1.0 g tension.
Contractions were measured as an increase in tension from
baseline. The reference for ACh-induced contraction is the mean
of three peak contractions in response to 5 mM ACh (Acros
Organics, Fair Lawn, NJ) at the start of each experiment. The
reference for EFS-induced contractions were the mean of 5
repetitive stimulations of ileum (10 Hz, 100 V, 0.2 ms, 5 s
duration every 30 s) and trachea (10 Hz, 100 V, 0.2 ms, 15 s
duration every 60 s), immediately following a 10–15 min period of
repetitive stimulation to allow tissues to achieve consistent
contractions.
Paraoxon (0.1–1 mM, final concentration), DMSO (0.1%, final
concentration), physostigmine (1–100 mM final concentrations;
Sigma-Aldrich) or 0.1% ethanol (vehicle for physostigmine) were
added to the baths, and 3 consecutive EFS-induced contractions
were recorded 0, 10, 15, 20, and 30 min after drug application. At
the end of the experiment, the stimulator was turned off and 5 mM
ACh-induced contractions were measured. Trachea and ileum
contractions induced by EFS and ACh were compared before
(baseline) and after paraoxon, DMSO, physostigmine or ethanol.
Blockade of EFS-induced and ACh-induced contractions by
100 mM atropine (Sigma-Aldrich) confirmed that all responses
were mediated via muscarinic receptor activation.
Acetylcholinesterase (AChE) activity
Following physiological experiments, lungs were perfused with
PBS, dissected, frozen on dry ice and stored at 280uC. At the end
of the organ bath experiments, trachea and ileum segments were
Figure 6. The organophosphorus fluorophosphonate (FP)
probe does not phosphorylate M2 muscarinic receptors in
guinea pig heart. Guinea pig heart cell membrane preparations with
abundant expression of M2 muscarinic receptors or BSA were reacted
with a fluorophosphonate tethered to a biotin group (FP-biotin) for
24 hr prior to separation by acrylamide gel electrophoresis. Blots of
these gels were probed with streptavidin tagged with an infrared
fluorophore (A, red in the merged image in panel C) to localize the
biotin tag and with anti-M2 receptor antibody conjugated to a different
infrared fluorophore (B, green in the merged image in panel C). As
indicated in the merged image (C), proteins in the heart membranes
that were biotinylated by the FP probe (red) did not co-localize with
bands recognized by the anti-M2 receptor antibodies (green).
doi:10.1371/journal.pone.0010562.g006
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blotted on filter paper, frozen on dry ice and stored at 280uC. On
the day of analysis, samples were thawed on ice, and AChE
activity measured using the Ellman assay [94] as previously
described [26].
Tissue Culture
The human neuroblastoma SK-N-SH cells (ATCC, Manassas,
VA) were maintained in Minimum Essential Medium containing
10% fetal bovine serum (FBS), nonessential amino acids, 1 mM
sodium pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin,
and 250 ng/ml amphotericin B (Mediatech, Inc., Manassas, VA).
Sympathetic neurons were dissociated from superior cervical
ganglia of perinatal rats and maintained in serum-free media
containing 125 ng/ml nerve growth factor as previously described
[95]. Cos-7 cells (ATCC, Manassas, VA) were conditioned to grow
in serum free media (VP-SFM, Invitrogen) and were transfected
with pCDNA encoding the full-length human M2 muscarinic
receptor cDNA [96] using Fugene6 transfection reagent (Roche,
Nutley, NJ) as described by the manufacturer. Transfection
efficiency was routinely 70–80%.
Quantitative reverse transcriptase polymerase chain
reaction (RT-PCR)
SK-N-SH cells were exposed to 0.1–1000 nM paraoxon, 0.1%
DMSO, or 2 ng/ml human tumor necrosis factor a (TNFa; Sigma-
Aldrich) for 4 or 24 hr at 37uC in 95% O2/5% CO2. Rat
sympathetic neurons (7 days in vitro) were exposed to 1–100 nM
paraoxon or 0.1% DMSO for 24 hr at 35uC at 95% O2/5% CO2.
RNA was isolated and reverse transcribed as previously described
[51]. cDNA (2 ml of a 1:10 dilution for M2 muscarinic receptor and
1 ml of a 1:100 dilution for 18S) was amplified for 45 cycles at 58uC
using QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA) in
duplicate using the 7500 Fast Real-Time PCR System (Applied
Biosystems, Foster City, CA). PCR products were quantified using
the Mx3000P real-time PCR System (Stratagene, La Jolla, CA).
Specific real-time PCR primers for the M2 muscarinic receptor and
18S rRNA were synthesized (Integrated DNA Technologies,
Coralville, IA) as follows: human M2 59 CAAAGGTCACACAC-
CACAGG and human M2 39 TTAAAGTCAACCGCCACCTC;
rat M2 59TACCCAGTTAAGCGGACCAC and rat M2 39GCA-
GATAGAACGCTGCAATG; 18S rRNA 59 GTAACCCGTT-
GAACCCCATT and 18S rRNA 39 CCATCCAATCGGTAG-
TAGCG. The relative amount of RNA was calculated from the slope
of a standard curve for each product and normalized to individual
18S RNA expression.
Muscarinic receptor expression assays
Surface expression of muscarinic receptors was determined
using tritiated scopolamine methyl chloride ([3H]-NMS; Perkin
Elmer, Waltham, MA) whereas total muscarinic receptor expres-
sion was determined using tritiated quinuclidinyl benzilate ([3H]-
QNB; Perkin Elmer) as previously described [97]. Both rat
sympathetic neurons and Cos-7 cells were treated with either
paraoxon (1–1000 nM) or vehicle alone (0.1% DMSO) for 24 hr
at 37uC in the presence or absence of the muscarinic agonist
carbachol (1 mM, Calbiochem, San Diego, CA). Cells were
subsequently reacted with 1 nM [3H]-NMS for 4 hr at 4uC or
with [3H]-QNB for 1 hr at 37uC in the absence or presence of
atropine (0.1 M, Sigma). The cells were lysed with 1% Triton X-
100 and radioactivity in cell lysates was quantified. Data are
presented as the specific binding, which was determined as counts
per minute (cpm) in the absence of atropine minus cpm in the
presence of atropine normalized to cell count (number of cells
plated in each culture). Every experiment was repeated 3–5 times
with 4–6 individual cultures per experiment.
Fluorophosphonate-biotin labeling in heart tissue
Guinea pig heart membranes were used for these experiments
because they express a high density of M2 receptors [98]. Hearts were
perfused with PBS, minced, suspended in 5 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES; pH 7.4) and homogenized
on ice. Homogenates were centrifuged at 10,0006g for 10 min at
4uC, and supernatants further centrifuged at 40,0006g for 30 min at
4uC. Pelleted heart membranes (1 mg total protein) were resus-
pended in 500 ml of 20 mM Tris (pH 7.4). Heart membranes and
bovine serum albumin (BSA; 0.5 mg/ml) were reacted with FP-biotin
(20 mM) for 24 hr at 20–25uC in the dark. FP-biotin was reacted with
BSA as a positive control for detection of phosphorylation by FP-
biotin [52]. Proteins were denatured with 5X sample buffer (10%
SDS, 10 mM b-mercaptoethanol, 20% glycerol, 0.2 M Tris-HCl,
pH 6.8) containing 8 M urea, separated on a 12% acrylamide gel
containing 4 M urea, and transferred to PDVF membrane. Protein
blots were blocked for 1 hr in Odyssey buffer (Licor, Lincoln, NE) and
incubated overnight at 4uC with a rabbit anit-M2 muscarinic
receptor antibody (M9558; Sigma-Aldrich) diluted 1:500 in buffer
containing 0.l% Tween-20. After several washes in PBS containing
0.1% Tween-20, protein blots were incubated for 2 hr at 20 –25uC
with an IR700-conjugated goat anti-rabbit secondary antibody
(1:1000; Rockland Immunochemical, Gilbertsville, PA) and an
IR800-conjugated strep avidin (1:5000; Rockland) in Odyssey buffer
containing 0.1% Tween-20 and 0.01% sodium dodecyl sulfate.
Immunoblots were washed and imaged on an Infrared Imaging
System (Licor). Images of FP-biotin and M2 muscarinic receptor
labeling were overlaid using Metamorph Imaging System (Universal
Imaging Corp., Downingtown, PA).
Data analysis
EFS-induced ileum and trachea contractions were analyzed by
two-way analysis of variance (ANOVA) with repeated measures.
Vagally- and ACh-induced broncho-constrictions were analyzed
by Student’s T-test. All other data were analyzed by one-way
ANOVA using the Bonferroni correction post-hoc test. Statistical
probability of p,0.05 was considered significant.
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